(Q34188703)

English

Phase II study of Aflibercept (VEGF-Trap) in patients with recurrent or metastatic urothelial cancer, a California Cancer Consortium Trial.

scientific article

Statements

Phase II study of Aflibercept (VEGF-Trap) in patients with recurrent or metastatic urothelial cancer, a California Cancer Consortium Trial. (English)
0 references
Przemyslaw Twardowski
Walter M Stadler
Paul Frankel
Primo N Lara
Christopher Ruel
Gurkamal Chatta
Elisabeth Heath
David I Quinn

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit